stella
beta
A Single Dose Study to Investigate the Pharmacokinetics (PK) of Telitacicept Pre-filled Injection and Freeze-dried Powder Injection in Chinese Healthy Subjects — Stella
Recruiting
Back to Healthy trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(3 sites)
China
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
West China Hospital of Sichuan University, Chengdu, Sichuan
Tianjin People's Hospital, Tianjin, Tianjin Municipality
View full record on ClinicalTrials.gov